Meet Patients Where They Are
Better Understand Patients' Lived Experiences
Leveraging publicly available data, in addition to commercial and consumer data, creates an even more robust and granular SDOH data asset that is not only normalized and primed for integration, but also designed to provide actionable insights to support business decisions throughout the entire product life cycle.
The Value of SDOH and Risk Metrics
1.
Social Factors (especially SDOH) significantly influence health outcomes and mortality and are being used increasingly to diversify datasets.
2.
There is a need to understand how best to integrate SDOH to act on resulting analytic derivatives in all aspects of the pharmaceutical pipeline.
3.
Deidentified social risk scores and metrics eliminate privacy concerns when aggregating data across sources, expediting certification for deidentification.